Literature DB >> 20840835

Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets.

A H Ellebedy1, M F Ducatez, S Duan, E Stigger-Rosser, A M Rubrum, E A Govorkova, R G Webster, R J Webby.   

Abstract

Early epidemiologic and serologic studies have suggested pre-existing immunity to the pandemic A (H1N1) 2009 influenza virus (H1N1pdm) may be altering its morbidity and mortality in humans. To determine the role that contemporary seasonal H1N1 virus infection or trivalent inactivated vaccine (TIV) might be playing in this immunity we conducted a vaccination-challenge study in ferrets. Vaccination with TIV was unable to alter subsequent morbidity or contact transmission in ferrets following challenge with H1N1pdm. Conversely, prior infection with the contemporary seasonal H1N1 strain altered morbidity, but not transmission, of H1N1pdm despite the detection of only minimal levels of cross reactive antibodies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20840835      PMCID: PMC3026885          DOI: 10.1016/j.vaccine.2010.08.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Authors:  John J Treanor; James D Campbell; Kenneth M Zangwill; Thomas Rowe; Mark Wolff
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

3.  Seasonal influenza vaccine provides priming for A/H1N1 immunization.

Authors:  Giuseppe Del Giudice; Koert J Stittelaar; Geert van Amerongen; James Simon; Albert D M E Osterhaus; Klaus Stöhr; Rino Rappuoli
Journal:  Sci Transl Med       Date:  2009-12-23       Impact factor: 17.956

4.  Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.

Authors:  Chih-Jen Wei; Jeffrey C Boyington; Kaifan Dai; Katherine V Houser; Melissa B Pearce; Wing-Pui Kong; Zhi-Yong Yang; Terrence M Tumpey; Gary J Nabel
Journal:  Sci Transl Med       Date:  2010-03-24       Impact factor: 17.956

5.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

6.  Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment.

Authors:  John Steel; Peter Staeheli; Samira Mubareka; Adolfo García-Sastre; Peter Palese; Anice C Lowen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.

Authors:  Jason A Greenbaum; Maya F Kotturi; Yohan Kim; Carla Oseroff; Kerrie Vaughan; Nima Salimi; Randi Vita; Julia Ponomarenko; Richard H Scheuermann; Alessandro Sette; Bjoern Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

8.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

9.  Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Authors:  Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

10.  Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.

Authors:  Lourdes Garcia-Garcia; Jose Luis Valdespino-Gómez; Eduardo Lazcano-Ponce; Aida Jimenez-Corona; Anjarath Higuera-Iglesias; Pablo Cruz-Hervert; Bulmaro Cano-Arellano; Antonio Garcia-Anaya; Elizabeth Ferreira-Guerrero; Renata Baez-Saldaña; Leticia Ferreyra-Reyes; Samuel Ponce-de-León-Rosales; Celia Alpuche-Aranda; Mario Henry Rodriguez-López; Rogelio Perez-Padilla; Mauricio Hernandez-Avila
Journal:  BMJ       Date:  2009-10-06
View more
  30 in total

1.  Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Authors:  Yuan Fang; David Banner; Alyson A Kelvin; Stephen S H Huang; Christopher J Paige; Steven A Corfe; Kevin P Kane; R Chris Bleackley; Thomas Rowe; Alberto J Leon; David J Kelvin
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.

Authors:  Leonard Moise; Ryan Tassone; Howard Latimer; Frances Terry; Lauren Levitz; John P Haran; Ted M Ross; Christine M Boyle; William D Martin; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-09-17       Impact factor: 3.452

3.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.

Authors:  Gillian M Air; Jingqi Feng; Tao Chen; Michelle L Joachims; Judith A James; Linda F Thompson
Journal:  J Clin Immunol       Date:  2011-07-06       Impact factor: 8.317

Review 5.  Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models.

Authors:  Jessica A Belser; Alissa M Eckert; Terrence M Tumpey; Taronna R Maines
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

6.  Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Authors:  Brian C Schanen; Anne S De Groot; L Moise; Matt Ardito; Elizabeth McClaine; William Martin; Vaughan Wittman; William L Warren; Donald R Drake
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

7.  APPENDIX 1: Evidence Review on Occupational Exposure of Swine and Poultry Workers: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2013-10-10

8.  Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

Authors:  R Bodewes; J H C M Kreijtz; M M Geelhoed-Mieras; G van Amerongen; R J Verburgh; S E van Trierum; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

9.  Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.

Authors:  Shabnam Alam; Andrea J Sant
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

10.  Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Geert van Amerongen; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Nella J Nieuwkoop; Peter van Run; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.